[{"id":"5be5a95f-e102-4e16-b57b-5d61222939d6","acronym":"","url":"https://clinicaltrials.gov/study/NCT03562637","created_at":"2021-01-18T17:32:00.713Z","updated_at":"2024-07-02T16:35:17.544Z","phase":"Phase 3","brief_title":"Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC","source_id_and_acronym":"NCT03562637","lead_sponsor":"OBI Pharma, Inc","biomarkers":" HER-2 • ER • PGR","pipe":" | ","alterations":" HER-2 negative • ER negative • PGR negative","tags":["HER-2 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • ER negative • PGR negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e capecitabine • adagloxad simolenin (OBI 822)"],"overall_status":"Recruiting","enrollment":" Enrollment 668","initiation":"Initiation: 12/05/2018","start_date":" 12/05/2018","primary_txt":" Primary completion: 12/30/2025","primary_completion_date":" 12/30/2025","study_txt":" Completion: 12/30/2027","study_completion_date":" 12/30/2027","last_update_posted":"2024-02-28"},{"id":"88cb2663-db0b-4a7f-afbf-dab9ca93c1b5","acronym":"","url":"https://clinicaltrials.gov/study/NCT01516307","created_at":"2021-01-18T06:22:26.933Z","updated_at":"2024-07-02T16:36:40.989Z","phase":"Phase 2","brief_title":"Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects","source_id_and_acronym":"NCT01516307","lead_sponsor":"OBI Pharma, Inc","biomarkers":" ER • PGR","pipe":" | ","alterations":" HER-2 positive • ER negative","tags":["ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • ER negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • adagloxad simolenin (OBI 822) • cyclophosphamide intravenous"],"overall_status":"Completed","enrollment":" Enrollment 349","initiation":"Initiation: 12/01/2011","start_date":" 12/01/2011","primary_txt":" Primary completion: 08/01/2016","primary_completion_date":" 08/01/2016","study_txt":" Completion: 08/01/2019","study_completion_date":" 08/01/2019","last_update_posted":"2020-09-16"}]